CA2803721A1 — Pharmaceutical composition comprising drospirenone and contraceptive kit
Assigned to Laboratorios Leon Farma SA · Expires 2012-01-05 · 14y expired
What this patent protects
The present invention relates to the field of pharmaceutical compositions and contraceptive methods. The present invention provides a pharmaceutical composition comprising drospirenone characterized by a slow dissolution rate of drospirenone in vitro and an improved pharmacokinet…
USPTO Abstract
The present invention relates to the field of pharmaceutical compositions and contraceptive methods. The present invention provides a pharmaceutical composition comprising drospirenone characterized by a slow dissolution rate of drospirenone in vitro and an improved pharmacokinetic profile. The use of the said composition in contraceptive methods and kits are also provided.
Drugs covered by this patent
- Slynd (DROSPIRENONE) · Exeltis Usa Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.